CMPX
Compass Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD2.10
+0.08 (+3.96%)
Rating:C
Company Profile
CEO
Thomas J. Schuetz
IPO Date
2021-04-05
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$2.02
Prev. Close
$2.02
Day Low
$2.02
Day High
$2.10
52W Low
$1.61
52W High
$6.88
Market Cap
$0.29B
Volume
1.62M